Search

Your search keyword '"Oligomers"' showing total 32,743 results

Search Constraints

Start Over You searched for: Descriptor "Oligomers" Remove constraint Descriptor: "Oligomers"
32,743 results on '"Oligomers"'

Search Results

151. Arbuzov meets 1,2-oxaphosphetanes: transient 1,2-oxaphosphetan-2-iums as an entry point to beta-halo phosphane oxides and P-containing oligomers.

152. Improved chemical recyclability of 2,5-furandicarboxylate polyesters enabled by acid-sensitive spirocyclic ketal units.

153. Effect of Oligomer Addition on Tube Dilation in Polymer Nanocomposite Melts.

154. Synthesis of Long‐Chain Oligomeric Donor and Acceptors via Direct Arylation for Organic Solar Cells†.

155. Amyloid oligomers and their membrane toxicity - A perspective study.

156. The Single Toxin Origin of Alzheimer's Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention.

157. Myelin Basic Protein Attenuates Furin-Mediated Bri2 Cleavage and Postpones Its Membrane Trafficking.

158. Synthesis of β-O-4 linked model oligolignol with a selectively deuterium-labelled methoxy group at the phenolic terminal unit.

159. Celastrol regulates the oligomeric state and chaperone activity of 𝛼B-crystallin linked with protein homeostasis in the lens.

160. Reduction of alpha-synuclein oligomers in preclinical models of Parkinson's disease by electrical stimulation in vitro and deep brain stimulation in vivo.

161. Synthesis of Long‐Chain Oligomeric Donor and Acceptors via Direct Arylation for Organic Solar Cells†.

162. Odd-Even Effect of Polyesters' Cyclic Oligomers and the Definition of Oligomers Based on Physicochemical Properties.

163. Pre-Polymer Chain Length: Influence on Permanent Memory Effect of PDLC Devices.

164. 'Prion-like' seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders

165. DNA nanostructures prevent the formation of and convert toxic amyloid proteospecies into cytocompatible and biodegradable spherical complexes

166. Microplastics and nanoplastics: Exposure and toxicological effects require important analysis considerations

167. Charge transfer excitons in π-stacked thiophene oligomers and P3[Alkyl]T crystals: CIS calculations and electroabsorption spectroscopy.

168. Dielectric constant of aqueous solutions of proteins and organic polymers from molecular dynamics simulations.

169. α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes

170. A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization

172. Investigation of serum amyloid a within animal species focusing on the 1-25 amino acid region

173. Kinetic profiling of therapeutic strategies for inhibiting the formation of amyloid oligomers.

175. Study Results from Gakushuin University Update Understanding of Antibodies (A novel monoclonal antibody generated by immunization with granular tau oligomers binds to tau aggregates at 423-430 amino acid sequence)

179. Acceptor-only oligomers with high coplanarity enable efficient and stable organic solar cells.

180. Quantitative Characterization of the Volatility Distribution of Organic Aerosols in a Polluted Urban Area: Intercomparison Between Thermodenuder and Molecular Measurements.

181. Restoring functional TDP-43 oligomers in ALS and laminopathic cellular models through baicalein-induced reconfiguration of TDP-43 aggregates.

182. How the Length of Through‐Space Conjugation Influences the Clusteroluminescence of Oligo(Phenylene Methylene)s.

183. α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes.

184. Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases.

185. Zwitterionic oligomers of 3-aminobenzoic acid on screen-printed electrodes: structure, properties and forensic application.

186. A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization.

187. Self‐Assembly of Discrete Oligomers of Naphthalenediimides in Bulk and on Surfaces.

188. Synthesis and thermal-optical behaviors of non-conventional benzidine-based oligomers containing tetrasubstituted Schiff base arms.

189. Stability and Electronic Properties of 1D and 2D Ca@C 60 Oligomers and Polymers.

190. Stabilization and Reduced Cytotoxicity of Amyloid Beta Aggregates in the Presence of Catechol Neurotransmitters.

191. Multiscale Modeling of Macromolecular Interactions between Tau-Amylin Oligomers and Asymmetric Lipid Nanodomains That Link Alzheimer's and Diabetic Diseases.

192. Formation of Silver Nanoparticles Oligomers Obtained via Laser Ablation in a Liquid by Sequential Centrifugation and Ultrasonication: Tunable Long-Wavelength Shift of Plasmon Resonance for Biomedical Applications.

193. Extension of use of isomalto‐oligosaccharide as a novel food pursuant to Regulation (EU) 2015/2283.

194. Unveiling the Role of Key Parameters during Molecular Growth for Optimal Poly(glycerol sebacate) Synthesis.

195. C9orf72-associated dipeptide protein repeats form All-positive oligomers in amyotrophic lateral sclerosis and frontotemporal dementia.

196. Installing hydrogen bonds as a general strategy to control viscosity sensitivity of molecular rotor fluorophores: Special Collection: Aggregation‐Induced Processes and Functions.

197. Effects of synthesis temperature on structures and properties of epoxidized soybean oil oligomers and starch‐based bioplastics.

198. Critical Review on High-Safety Lithium-Ion Batteries Modified by Self-Terminated Oligomers with Hyperbranched Architectures.

199. Illumina reads correction: evaluation and improvements.

200. M13 phage grafted with peptide motifs as a tool to detect amyloid-β oligomers in brain tissue.

Catalog

Books, media, physical & digital resources